FDA Warns Glaxo on Hypertension Drug Marketing

WASHINGTON (Reuters) - The U.S. Food and Drug Administration warned GlaxoSmithKline Plc on Thursday over misleading advertisements touting its hypertension drug called Coreg.

Continue to FDA Warns Glaxo on Hypertension Drug Marketing on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz